Insights from Yu Rong, Cai Daqing, and Song Jingwei at the '2017 Top 100 Future Healthcare' Forum
1
# This Week's Hot Topics
#2017 Future Healthcare 100: A Review of Key Insights#
The “2017 Top 100 Future Healthcare Companies” Forum, themed “Era of Species Explosion,” was held at the Beijing Marriott Hotel from December 15 to 17, 2017.
Mr. Yu Rong, Chairman of Meinian Onehealth Healthcare Industry Holdings Co., Ltd. and Chairman of Tianyi Investment (Group) Co., Ltd., delivered a speech on the theme “Building a Health Platform and Constructing a Medical and Health Ecosystem.”Cai Daqing, Managing Director at Legend Capital, delivered an insightful speech titled “My Understanding of New Technologies: The Core Driving Force in the New Healthcare Reform.”Ms. Song Jingwei, Co-Founder of Xiao Dou Miao, delivered a speech on the theme “Children’s Health Starts with Prevention.”VCBeat (WeChat: vcbeat) has compiled the guests' viewpoints.
Perspective:
1• Yu Rong: Sharing Our Insights on the Industry—What Is Meinian Planning to Do?
Regarding the healthcare sector, I would also like to outline the major opportunities for the industry as a whole in the future, taking into account current policy trends and guidance. The key points are as follows:
First, in the medical profession—whether involving devices, pharmaceuticals, or services—there is a distinct shift toward upstream intervention and early-stage engagement, with a clear trend toward precision prevention. The underlying logic is tied to broader socioeconomic structures; simply put, national budgets and government coffers worldwide are insufficient to cover the costs associated with increasing human longevity, thereby compelling the industry to move proactively toward prevention.
Second, improve healthcare efficiency from the perspectives of data, standards, and intelligence. Digitization, standardization, and intelligentization have been hot topics in recent years;
Third, in terms of medical services, we are optimistic about breakthroughs in specialized care and the integration of medical and elderly care. Regarding medical services, the prospects are promising for the next 5–10 years, particularly for non-public hospital enterprises achieving breakthroughs in specialized fields.
Finally, we observe certain drivers stemming from market-oriented reforms and policy changes, such as the marketization of physicians and the platformization of healthcare institutions.
Key Elements of Innovation and Entrepreneurship in the Health and Medical Sector: I Have Distilled Several Keywords—Closed Loop, Data, Primary Care, and Finance.
2. Cai Daqing: The investment in iFlytek and Berry Genomics was driven by a focus on technology, as new technologies will be the core driver of the new healthcare reform.
In the fields of new drug development and gene technology, which are gradually emerging as prominent forces in the healthcare sector, companies often face a severe shortage of qualified talent during recruitment.
In addition to the explosive emergence of new technologies, cross-pollination among various emerging technologies has given rise to a new wave of achievements. For instance, in the fields of cell therapy and gene technology: novel discoveries in gene technology have accelerated the rapid development of cytology, while advances in cell research have, in turn, driven progress in gene technology.
We are investing in emerging technologies that will yield results within the next three to five years, while strategically positioning ourselves for the five-to-seven-year and seven-to-ten-year horizons.
In China, we believe that technological progress has become one of the leading forces driving industry development—and this is a rather modest assessment. Ten to fifteen years ago, many industries were actually driven primarily by policy and market dynamics. To some extent, during that period, the influence of policy and market factors outweighed the changes brought about by new technologies.
The domestic market in China is vast, so even inferior products can gain traction. Through various manipulative tactics within the market, these companies may proceed to go public. Conversely, if regulatory policies prohibit it, even superior technology will be left sidelined. In contrast, the situation abroad is quite different, with European and American countries maintaining a relative technological lead.
3. Song Jingwei: Pioneering Vaccination + Internet to Build an Immune Barrier
Xiaodoumiao is a young company that has been in existence for just three years since its founding. Transitioning from traditional industries to pursue “Internet Plus” initiatives has opened up an entirely new frontier for our team. We have been proactively exploring and learning through trial and error, advancing with a mindset dedicated to continuous learning.
The upgrading of health-related consumption is an undeniable trend in the consumer market. Across all age groups and socioeconomic strata, we are witnessing a growing expenditure on preventive health, marking a significant shift at the market level.
From a macro-policy perspective, whether it is the “Healthy China 2030” Planning Outline issued by the State Council, the report of the 19th National Congress of the Communist Party of China, or recent economic reports, a clear shift is evident: disease treatment must be reoriented toward prevention, with corresponding plans and requirements put forward for the health industry.
Driven by policy, the health industry should be ushering in a new spring, and I believe this phase will last for quite some time.
When it comes to prevention, vaccination is widely recognized as the fastest, most effective, and most precise approach to maintaining health. However, unlike other health products, its significance extends far beyond this individual benefit. Vaccination helps establish a robust immune barrier, which is why governments and countries around the world pay particular attention to its development.
From another perspective, the establishment of an immune barrier is also a reflection of a country’s comprehensive national strength; therefore, the Chinese government has incorporated vaccination into its unified system. Another significant aspect of vaccines is that large-scale inoculation fully demonstrates their social value and benefits.
How to Establish an Immune Barrier? Two Key Factors. The first is high-quality products and advanced technologies to provide broader disease coverage and enhance quality. The other key factor is achieving high vaccination rates to offer better protection for society.
Xiaodoumiao aims to increase vaccination coverage rates, support public health management, and enhance the普及率 of preventive vaccinations through targeted solutions.
In 2014, Xiao Dou Miao launched its “Vaccination + Internet” service, initially focusing on pediatric immunization. Childhood vaccination is an essential need, as infants require vaccinations from birth.
How large is the population? Following the relaxation of the two-child policy, there are approximately 18 million newborns annually. Furthermore, vaccination represents a high-frequency use case, particularly during the 0–3 years age group; completing the full vaccination schedule requires more than 20 doses in total.
In summary, vaccination holds significant importance for individuals, the industry, and public social management; however, numerous challenges and difficulties do arise during its practical implementation.
Report:
2
This Week's Headlines
3
This Week's Financing Events in the Healthcare Sector
4
Upcoming Events in the Medical and Healthcare Sector
5
This Week's Industry Updates
6
This Week's In-Depth Report
For more content, please refer to the VCBeat knowledge base!
